- Lobbying
- Lobbying by Lundbeck, Inc.
Lobbying Relationship
Bills mentioned
H.R.3200: America's Affordable Health Choices Act of 2009
Sponsor: John D. Dingell (D-Mich.)
S.301: Physician Payments Sunshine Act of 2009
Sponsor: Charles E. Grassley (R-Iowa)
S.525: Pharmaceutical Market Access and Drug Safety Act of 2009
Sponsor: Byron L. Dorgan (D-N.D.)
H.R.1298: Pharmaceutical Market Access and Drug Safety Act of 2009
Sponsor: Marion Berry (D-Ark.)
H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act
Sponsor: Henry A. Waxman (D-Calif.)
H.R.1548: Pathway for Biosimilars Act
Sponsor: Anna G. Eshoo (D-Calif.)
S.726: Promoting Innovation and Access to Life-Saving Medicine Act
Sponsor: Charles E. Schumer (D-N.Y.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
John M. Haddow | Legislative Assistant |
William Nixon | Senior Policy Advisor/Communications Director |
Matthew Salmon | U.S. Representative from Arizona's 1st District |
John Drew Hiatt | Staff Director for the Small Business District |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Senate
Senate
Senate
Senate
Senate
Senate
Senate
Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate